Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
115597-84-7
86099-06-1
1421933-37-0
79364-17-3
146551-23-7
660843-22-1
350999-89-2 | 3-(4-Ethylphenyl)-1h-pyrazole-4-carbaldehyde | AA00I6VI | MFCD01993814
35899-43-5 | (R)-L-(+)-Boc-His(Tos)-OH | AA00I71D | MFCD00065967
368435-46-5 | (3-Amino-5-iodophenyl)methanol | AA00I77S | MFCD18389627
37801-47-1 | Ethyl 4-chloro-1-ethyl-3-methyl-1h-pyrazolo[3,4-b]pyridine-5-carboxylate | AA00I7DC | MFCD04124526
383133-78-6 | 6-(Pentyloxy)-1H-indole-2-carboxylic acid | AA00I7IH | MFCD02664539
3952-78-1 | Glycine,N-(carboxymethyl)-N-[(9,10-dihydro-3,4-dihydroxy-9,10-dioxo-2-anthracenyl)methyl]- | AA00I7P9 | MFCD00149067
40348-66-1 | (R)-1,2-Butanediol | AA00I7U2 | MFCD09953765
41263-72-3 | N-Methyl-4-(methylamino)-3-nitrobenzamide | AA00I7ZZ | MFCD12197094
4264-82-8 | 5-Bromo-4-chloro-3-indolyl-n-acetyl-beta-d-glucosaminide | AA00I85W | MFCD00040631
443642-31-7 | 1-O-Methyl-3,5-bis-o-[(2,4-dichlorophenyl)methyl]-2-c-methyl-alpha-d-ribofuranoside | AA00I8C0 | MFCD06795888
